{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:59:02Z","timestamp":1788901142352,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.jaad.2006.12.003","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T07:09:18Z","timestamp":1182236958000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously\u00a0treated with other biologics"],"prefix":"10.1016","volume":"57","author":[{"given":"Marina","family":"Papoutsaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Sole","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Talamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Zangrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.12.003_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-3083.2003.00720.x","article-title":"The role of T cells in psoriasis","volume":"17","author":"Prinz","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.12.003_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis \u2014 epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.12.003_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Schon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2006.12.003_bib5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.9.7.1511","article-title":"Psoriatic arthritis","volume":"9","author":"Gladman","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2006.12.003_bib6","first-page":"11","article-title":"Efficacy and safety of treatment modalities for psoriasis","volume":"61","author":"Tristani-Firouzi","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.12.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2710.2000.00254.x","article-title":"Therapeutic strategies for psoriasis","volume":"25","author":"Ashcroft","year":"2000","journal-title":"J Clin Pharm Ther"},{"issue":"Suppl 69","key":"10.1016\/j.jaad.2006.12.003_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06070.x","article-title":"Biologicals in psoriasis consensus","volume":"151","author":"Sterry","year":"2004","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.12.003_bib9","first-page":"S57","article-title":"Generation of fully human anti-TNF antibody D2E7","volume":"41","author":"Salfeld","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.jaad.2006.12.003_bib10","first-page":"P8","article-title":"Long-term safety and\u00a0efficacy of adalimumab in the treatment of moderate to\u00a0severe chronic plaque psoriasis","volume":"52","author":"Langley","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib11","first-page":"393","article-title":"Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis","volume":"37","author":"Ritchie","year":"1968","journal-title":"Q J Med"},{"key":"10.1016\/j.jaad.2006.12.003_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.12.003_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2014 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"Ten years experience of the Dermatology Life Quality Index (DLQI D)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2006.12.003_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2230.1987.tb01844.x","article-title":"Psoriasis \u2014 an index of disability","volume":"12","author":"Finlay","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14740338.4.4.637","article-title":"Adalimumab: a review of side effects","volume":"4","author":"Scheinfeld","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2006.12.003_bib17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudari","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.12.003_bib18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate to severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.12.003_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Enbrel (etanercept) in patients with psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2006.12.003_bib20","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaad.2006.12.003_bib21","first-page":"73","article-title":"Efficacy and safety of\u00a0long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis","volume":"141","author":"Bianchi","year":"2006","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.12.003_bib22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780281203","article-title":"How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?","volume":"28","author":"Sharp","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2006.12.003_bib23","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with\u00a0moderately to severely active psoriatic arthritis","volume":"52","author":"Mease","year":"2005","journal-title":"Artthitis Rheum"},{"key":"10.1016\/j.jaad.2006.12.003_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2006.05.027","article-title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study","volume":"55","author":"Gordon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-2133.2005.06582.x","article-title":"Extensive plaque psoriasis successfully treated with adalimumab (Humira\u00ae)","volume":"152","author":"Sladden","year":"2005","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2133.2004.06105.x","article-title":"Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab","volume":"151","author":"Chew","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.12.003_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2133.2005.06759.x","article-title":"Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin","volume":"153","author":"Tobin","year":"2005","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206041041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206041041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:06:33Z","timestamp":1759269993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206041041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0190962206041041"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.12.003","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously\u00a0treated with other biologics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}